MediciNova (TSE:4875) Total Operating Expense: 円1,960.45 Mil (TTM As of Mar. 2026)

What is MediciNova Total Operating Expense?

MediciNova TSE:4875 +2.26% 28 Total Operating Expense is 円1,960.45 Mil as of Mar. 2026. GuruFocus rates TSE:4875 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

MediciNova's Total Operating Expense for the three months ended in Mar. 2026 was 円452.72 Mil. MediciNova's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,960.45 Mil.

MediciNova Total Operating Expense Related Terms

MediciNova Total Operating Expense Historical Data

* Premium members only.

The historical data trend for MediciNova's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediciNova Total Operating Expense Chart

MediciNova Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Operating Expense

Get a 7-Day Free Trial

1,622.57

1,973.67

1,569.40

1,949.60

2,075.85

MediciNova Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Operating Expense	Get a 7-Day Free Trial															477.43	523.75	501.11	482.87	452.72

28GF Score

MediciNova Inc TSE:4875

Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

MediciNova Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,960.45 Mil.

Frequently Asked Questions Learn more about Total Operating Expense →

What does a Total Operating Expense of 円1,960.45 Mil mean?

MediciNova (TSE:4875) has a Total Operating Expense of 円1,960.45 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on MediciNova and its competitors.

Is MediciNova's Total Operating Expense too high?

MediciNova's current Total Operating Expense is 円1,960.45 Mil. Overall, MediciNova has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.

How does MediciNova's Total Operating Expense compare to TCRX and PMVP?

MediciNova's Total Operating Expense of 円1,960.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Operating Expense for a Biotechnology company?

A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Operating Expense mean?

A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on MediciNova and its competitors. MediciNova's current Total Operating Expense is 円1,960.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is MediciNova stock overvalued right now?

MediciNova (TSE:4875) has a current Total Operating Expense of 円1,960.45 Mil. The current Total Operating Expense is 円1,960.45 Mil. MediciNova's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Operating Expense calculated?

Total Operating Expense is calculated from a company's financial statements. For MediciNova (TSE:4875), the current Total Operating Expense is 円1,960.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MediciNova Business Description

Industry Healthcare Biotechnology

Comparable Companies TCRX PMVP BSEM CING IMA XLO FLNA MCRB BOLD PLRX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges MNOV:USA

Address 4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037

Website https://www.medicinova.com

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

28GF Score

Get the complete analysis for TSE:4875

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円226.00

Price

View TSE:4875 Analysis

See Total Operating Expense data for all stocks →